Skip to main content
Continental Chemicals Ltd. logo

Continental Chemicals Ltd. — Investor Relations & Filings

Ticker · 506935 ISIN · INE423K01015 BSE.NS Manufacturing
Open in API
Filings indexed 488 across all filing types
Latest filing 2020-07-28 Regulatory Filings
Country IN India
Listing BSE.NS 506935

About Continental Chemicals Ltd.

https://www.continentalchemicalsltd.com/

Continental Chemicals Ltd. specializes in the manufacturing and marketing of soaps, detergents, and personal care products. The company’s core operations involve the production of a diverse range of cleaning agents, including laundry soaps, detergent powders, and liquid detergents. Its product portfolio also encompasses toilet soaps and specialized hygiene solutions tailored for household and institutional applications. Established with a focus on formulation quality and product efficacy, the organization leverages its extensive experience to provide essential sanitation and cleaning goods. The company maintains a commitment to consistent product standards and distribution efficiency, catering to broad consumer needs for hygiene and maintenance products.

Recent filings

Filing Released Lang Actions
we would like to inform you that as per the ''Code of Conduct for Prevention of Insider Trading'' pursuant to the amended SEBI (Prohibition of Insider Trading) Regulations, 2015, the Company ....
Regulatory Filings Classification · 95% confidence The document is a notification to the stock exchange about an upcoming Board meeting scheduled to consider and take on record the audited quarterly and yearly financial results for the quarter and year ended March 31, 2020. It also informs about the closure of the trading window as per insider trading regulations. The document is short (1507 characters) and serves as an intimation or announcement rather than containing the actual financial results or detailed report. Therefore, it is an announcement related to a Board meeting and financial results, fitting the category of a Regulatory Filing (RNS) as it does not contain the full report or detailed financial data itself.
2020-07-28 English
CONTINENTAL CHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2020 ,inter alia, to consider and approve The Board meeting will ....
Regulatory Filings Classification · 95% confidence The document is a notification to the stock exchange about an upcoming Board meeting scheduled for July 31, 2020, to consider and take on record the audited quarterly and yearly financial results for the quarter and year ended March 31, 2020. It also mentions the closure of the trading window as per insider trading regulations. The document does not contain the financial results themselves but is an announcement of the meeting where these results will be considered. The document length is short (1507 characters) and serves as an intimation rather than the report itself. Therefore, it fits the category of Capital/Financing Update (CAP) or Regulatory Filings (RNS). However, since it specifically relates to a Board meeting notice for financial results, it is best classified as a Regulatory Filing (RNS) under SEBI regulations for disclosure. Confidence is high due to clear regulatory references and the nature of the document as a meeting notice rather than a report or results release.
2020-07-28 English
Certificate under Reg. 74(5) of SEBI (DP) Regulation, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, issued by the Registrar and Share Transfer Agent. It confirms compliance with dematerialization procedures for securities during the quarter ended June 2020. The document is a formal certification letter addressed to the Bombay Stock Exchange and does not contain financial statements, management discussion, or detailed financial data. It is not an annual or interim report, earnings release, or any other financial report type. It is also not an announcement of a report but a regulatory compliance certificate. Therefore, it fits best under Regulatory Filings (RNS) as a certification document related to regulatory compliance.
2020-07-17 English
Closure of trading window
Regulatory Filings Classification · 95% confidence The document is a notification to the stock exchange about the closure of the trading window for insiders in compliance with insider trading regulations. It references the upcoming financial results for the quarter ending June 30, 2020, but does not contain any financial data or results itself. It is a regulatory announcement related to trading restrictions rather than a financial report or earnings release. The document length is short (1373 characters) and it serves as a formal notice to the exchange. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2020-07-09 English
Mr. Dhiraj Kuamr Chowdhary Director of the company resigned as Director of the company as per his email received after office hours late evening yesterday. Kindly take the same on your records.
Board/Management Information Classification · 100% confidence The document is a formal notification addressed to the Bombay Stock Exchange regarding the resignation of a company director, Mr. Dhiraj Kumar Chowdhary, effective from 6th July 2020. It is an announcement about a change in the company's board of directors. There is no financial data, report, or other regulatory filing content. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2020-07-07 English
Update
Regulatory Filings Classification · 95% confidence The document is a letter addressed to BSE Limited referencing Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It provides an update on the company's operational status due to COVID-19 impacts, mentioning inability to resume operations and the premises being in a red zone. The letter states that the company will evaluate the impact on business and financials and disseminate further information in due course. The document is short (1596 characters) and serves as a regulatory update rather than a detailed financial report or formal filing. It does not contain financial statements or detailed analysis but is a compliance communication under SEBI regulations. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance updates that do not fit other specific categories.
2020-06-26 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.